Our Recommendations
New Publications
- Overview of capacity building opportunities in “One Health”, internationally and with focus on Africa (2022)
- Publication: Gendered Impacts of the COVID-19 Crisis in Uganda and Opportunities for an Inclusive and Sustainable Recovery (2022)
- Cum să faci ceea ce contează în perioade stresante: Un ghid ilustrat (2020)
- Важные навыки в периоды стресса: иллюстрированное пособие (2020)
- Sharing successful strategies from the Eastern Mediterranean Region in mitigating noncommunicable diseases and mentalhealth disorders during the COVID-19pandemic and beyond (2023)
Filter
4325
Featured
Recommendations
657
New Publications
13
Language
Document type
Guidelines
1246
Fact sheets
631
Studies & Reports
587
Infographics
427
Manuals
268
Resource Platforms
251
Videos
217
Situation Updates
163
Strategic & Response Plan
153
Training Material
112
Online Courses
96
Brochures
83
No document type
78
App
9
Dashboards/Maps
4
Countries / Regions
Russia
254
Germany
236
Brazil
194
Latin America and the Carribbean
173
Global
164
India
150
Middle East and North Africa
141
West and Central Africa
121
South Africa
103
Mozambique
101
East and Southern Africa
96
Eastern Europe and Central Asia
95
Syria
89
Angola
85
Africa
78
Yemen
74
Colombia
65
Western and Central Europe
57
South Sudan
55
Spain
49
Guinea-Bissau
45
Argentina
43
Peru
42
Ecuador
40
Kenya
38
Ukraine
37
Congo, Democratic Republic of
37
Burkina Faso
35
South–East Asia Region
30
Bangladesh
30
Eastern Europe
29
Chile
28
Italy
28
Mali
28
Senegal
27
Venezuela
27
Portugal
27
Nigeria
25
Haiti
25
Paraguay
25
Ethiopia
23
Indonesia
23
China
22
Bolivia
22
Canada
21
Côte d’Ivoire / Ivory Coast
21
Niger
19
Somalia
19
Myanmar / Burma
19
Singapore
18
El Salvador
17
Lebanon
17
Vietnam
17
Sudan
17
Philippines
15
Mexico
14
United Kingdom
14
Uganda
14
Cameroon
13
France
13
Ghana
12
Guinea
12
Western Pacific Region
12
Nepal
11
Kazakhstan
11
Malaysia
11
Iraq
11
Pakistan
11
Thailand
10
Turkey
10
Benin
10
Sierra Leone
10
Rwanda
10
Malawi
10
Chad
10
Zambia
10
Liberia
10
Iran
9
Congo-Brazzaville
9
Afghanistan
9
Luxembourg
9
Honduras
9
Madagascar
9
Tajikistan
8
Burundi
8
Saudi Arabia
8
Algeria
8
Switzerland
7
Austria
7
Cambodia
7
Tanzania
7
Tunisia
7
Sri Lanka
7
Djibouti
7
Central African Republic
7
Kyrgyzstan
6
Zimbabwe
6
USA
6
Jordan
6
Ireland
6
Nicaragua
6
Moldova
6
Egypt
6
Libya
6
Guatemala
6
Togo
5
Laos
5
Uzbekistan
5
Mauritania
5
Dominican Republic
5
Japan
5
South Korea
5
Palestine
5
Morocco
4
Uruguay
4
Turkmenistan
4
Belarus
4
Greece
4
North Korea
3
Belgium
3
Georgia
3
Cuba
3
Serbia
2
Asia
2
Cape Verde
2
North America
2
Gabon
2
Jamaica
2
Denmark
2
Mauritius
2
French Guyana
2
Papua New Guinea
2
Namibia
2
North Macedonia
1
Timor Leste/ East Timor
1
Lesotho
1
Australia
1
Gambia
1
Mongolia
1
Qatar
1
Armenia
1
Croatia
1
Hungary
1
Morocco
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Southern Africa
1
Romania
1
Poland
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
2169
Key Resources
151
Women & Child Health
97
Capacity Building
69
Clinical Guidelines
54
Public Health
35
Pharmacy & Technologies
27
Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Administration of Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
Acessed on 15.08.2022
Recursos de información COVID-19 - Argentina - OPS/OMS | Organización Panamericana de la Salud
Website
Acessed on 15.08.2022
Estudio sobre los efectos en la salud mental de personas gestantes por COVID-19
Website
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafety and biosecurity practices associated with the design, commissioning, routine operation safe and secure biocontainment laboratories.
Int. J. Environ. Res. Public Health 2022, 19, 9313. https://doi.org/10.3390/ijerph19159313. A mixed-methods study, using an online survey and in-depth interviews, was conducted. Participants included Mental Health Focal Points at the Ministries of Health, the World Health Organization (WHO) country ...
Following a long recovery from the economic crisis (2007–2013), young people in the EU proved to be more vulnerable to the effects of the restrictions put in place to slow the spread of the COVID-19 pandemic. Young people were more likely than older groups to experience job loss, financial insecur...
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
first issued 18 August 2022
Latin America and the Caribbean is characterized by a matrix of social inequality whose axes —such as
socioeconomic stratum, gender, stage in the life cycle, ethnicity and race, territory, disability, and immigration
status— create multiple, often concurrent, situations of exclusion and discri...
For patients on HFNO with persistent hypoxaemia or respiratory distress:
• Check the equipment: inspect the exterior of the machine, the tubing (circuit), the prong for any sign of mechanical damage, confirm it fits and the filters are in place. Ensure the settings are appropriate and flow is max...
WHO recommends prompt recognition of progressive acute hypoxaemic respiratory failure when a patient with respiratory distress is failing to respond to standard oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory support.
Hypoxaemic respiratory failure in ARDS commonly re...
Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19: Recognize ARDS
recommended
WHO recommends prompt recognition of progressive acute hypoxaemic respiratory failure when a patient with respiratory distress is failing to respond to standard oxygen therapy and adequate preparation to provide advanced oxygen/ventilatory support.
Hypoxaemic respiratory failure in ARDS commonly ...
For patients on NIPPV or HFNO with persistent hypoxaemia or respiratory distress:
• Check the equipment: inspect the exterior of the machine, the tubing (circuit), the mask for any sign of mechanical damage, confirm it fits securely without leak (if CPAP/BiPAP) and the filters are in place. Ensur...
